Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6021041 | 0.91 | TACR1 (0.78) | TACR1 | |
| SCHEMBL6531214 | 0.90 | TACR1 (0.62) | TACR1GPBAR1 | |
| SCHEMBL905384 | 0.89 | TACR1 (0.85) | TACR1GPBAR1 | |
| SCHEMBL6021068 | 0.85 | TACR1 (0.52) | TACR1 | |
| SCHEMBL21235999 | 0.84 | TACR1 (0.82) | TACR1GPBAR1 | |
| SCHEMBL905333 | 0.84 | TACR1 (0.85) | TACR1GPBAR1 | |
| SCHEMBL21235997 | 0.82 | TACR1 (0.86) | TACR1GPBAR1 | |
| SCHEMBL905343 | 0.80 | TACR1 (0.78) | TACR1GPBAR1 | |
| SCHEMBL29467378 | 0.80 | TACR1 (1.00) | TACR1GPBAR1 | |
| SCHEMBL905330 | 0.80 | TACR1 (1.00) | TACR1GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110053954-A1 | METHOD OF TREATMENT AND/OR PREVENTION OF BRAIN, SPINAL OR NERVE INJURY | HOFFMANN TORSTEN | 2011-03-03 | — | — | US | disclosed |
| US-20060247240-A1 | Method of treatment and/or prevention of brain, spinal or nerve injury | HOFFMANN TORSTEN | 2006-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110053954-A1 | METHOD OF TREATMENT AND/OR PREVENTION OF BRAIN, SPINAL OR NERVE INJURY | NTSR1, NTRK2, NMUR1 | TACR1 14/4885GPBAR1 430/4885 |
| US-20060247240-A1 | Method of treatment and/or prevention of brain, spinal or nerve injury | NTSR1, NTRK2, NMUR1 | TACR1 10/4885GPBAR1 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.